April 18, 2019
Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The decision was made in response to weak demand and purchases from customers.
"We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an...
January 24, 2017
Madison, Wisconsin-based Redox, which makes APIs to create interoperability between healthcare organizations and developers, has raised $9 million in Series B funding in a round led by RRE Ventures. Existing investors .406 Ventures, HealthX Ventures and Flybridge Capital Partners also contributed to the round. In 2015, the company raised $3.5 million, and this latest financing brings their total...
August 17, 2016
IBM Watson Health announced that its Watson for Oncology program, trained at Memorial Sloan Kettering Hospital, will be rolled out to 21 hospitals throughout China. The initial 21-hospital introduction is the beginning of a multi-year partnership through which IBM's Chinese partner Hangzhou CognitiveCare will introduce Watson for Oncology to hospitals across China. More.
CareMore Health System ...
October 20, 2015
Madison, Wisconsin-based Redox, a company founded by former Epic engineers that makes an API for integrating software with EHRs, has raised $3.5 million in a round led by .406 Ventures. Flybridge Capital Partners and HealthX Ventures also contributed to the round.
The company is attempting to address a major pain point in developing software for hospitals: integration and interoperability with...